WidePoint Corporation Secures $110,000 Contract to Provide DaaS Support for Federal Health Research Agency

Reuters
23 Jun
WidePoint Corporation Secures $110,000 Contract to Provide DaaS Support for Federal Health Research Agency

WidePoint Corporation, a provider of Trusted Mobility Management solutions, has announced a new contract to deliver Device as a Service (DaaS) management and support for a prominent Federal health research agency. The one-year contract, valued at $110,000, aims to streamline the deployment and lifecycle management of advanced technologies essential for innovative health solutions. This collaboration marks the first of several potential DaaS opportunities with a strategic Fortune 500 partner. WidePoint's CEO, Jin Kang, emphasized the company's expertise in asset management and DaaS solutions, highlighting their commitment to providing efficient, secure, and transparent device ecosystem management. The initiative will leverage WidePoint's Intelligent Technology Management System (ITMS) platform to offer comprehensive oversight and automation, allowing organizations to focus on their core mission while utilizing reliable and compliant technology services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WidePoint Corporation published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1041779) on June 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10